chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness in face and tongue, worse over time; Numbness in face and tongue; Impairing her speech; Impairing her ability to eat; This case was reported by a consumer via call center representative and described the occurrence of numbness facial in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included breast cancer (she completed chemotherapy and radiation as well as a lumpectomy for breast cancer).   In April 2019, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced numbness facial, numbness of tongue, speech disorder and eating disorder. On an unknown date, the outcome of the numbness facial was not recovered/not resolved and the outcome of the numbness of tongue, speech disorder and eating disorder were unknown.   It was unknown if the reporter considered the numbness facial, numbness of tongue, speech disorder and eating disorder to be related to Shingrix.  Additional details were reported as follows: The patient self-reported this case. The patient called in for the information regarding side effect she developed after receiving Shingrix. The reporter noted that she received her first dose of Shingrix in April of 2019 (exact date unknown) two weeks after she completed chemotherapy and radiation as well as a lumpectomy for breast cancer. After receiving the vaccination on the same day, she noticed some numbness on the right side of her face. She stated that this had gotten worse over time, with the numbness extending to her tongue and impairing her speech and ability to eat.  The reporter stated that due to this reason, she refused to receive the second dose of Shingrix. The reporter stated that she had been seen by multiple physicians including neurologists who ran tests but determined she did not had Guillain-Barre.  The reporter requested further information on Shingrix for which, she was provided with the Medical Information number for her healthcare professional to reach out for more information. The reporter consent to follow up and gave permission to contact health care professionals.
This spontaneous report as received from a physician refers to a female teenaged patient. The physician stated that he received an e-mail from a colleague that said a "Teenaged female patient was hospitalized at a hospital, with acute disseminated encephalomyelitis (which started in August 2012, "within last month") two weeks after she received an injection of GARDASIL (0.5 ml, intramuscularly, Lot# unspecified). The patient had sought unspecified medical attention. The outcome was unknown. Acute disseminated encephalomyelitis was considered to be life-threatening by reporter. Additional information has been requested.
Reported by patient husband - on 1/20/14 - pt said flu shot on 10/11/13 "felt different" than other flu shots in past. Injection site was very sore and soreness persists today. Pt reportedly cannot lift arm above head/has trouble lifting. Pt. has not informed primary MD. Pharmacy first informed on 1/20/14.
Paresthesia (pringling, itching feeling) all over body, comes and goes.  Tingling and numbness in right hand.
at the injection site, it is raised, warm and red; at the injection site, it is raised, warm and red; at the injection site, it is raised, warm and red; This is a spontaneous report from a contactable other health professional (HCP). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on her right arm, on 06Jan2021 at a single dose for COVID-19 immunization. Medical history was reported as none. There were no concomitant medications. Patient received the first vaccine 2 days ago (06Jan2021) and last night (07Jan2021) at the injection site, it is raised, warm and red.  She has had no other symptoms and no fever. She was asking if it is normal for it to take time to occur and for how long will it last. On 08Jan2021, it was reported that she did see that it was normal but was asking if it is normal 48 hours later. Otherwise, she was completely fine. She works as a technician at the hospital. She just took a picture of it so she can keep track of it. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Fever started 8 days after the shots & was as high as 102.2F. Two days after fever started he got a rash that spread that day over his entire body. The rash was bright red raised. It did not seem to bother him. The fever continued for 5 days and the rash started to fade after a week but was visible 2-3 weeks.
Information has been received from a physician and health professional concerning a 5 year old male with no known drug allergies and history of bronchospasm, who on 05/05/1997 was vaccinated with the first dose of varicella vaccine SC in his left. At the time of the vaccination, the pt had bilateral cloudy effusion of his ears. he had no fever or other complaints. He was placed on therapy Bactrim. On 06/26/2001, the pt was evaluated at the physician's office and diagnosed with chicken pox. The pt had varicella lesions on his face, arms, trunk and back. Greater than 100 lesions were noted. Subsequently, the pt recovered. No additional info is expected.
Could the vaccine cause fibromyalgia; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FIBROMYALGIA (Could the vaccine cause fibromyalgia) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FIBROMYALGIA (Could the vaccine cause fibromyalgia). At the time of the report, FIBROMYALGIA (Could the vaccine cause fibromyalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.
Information has been received from a 65 year old male with no allergies, blood pressure and cholesterol, who in 2009 was vaccinated with ZOSTAVAX (Merck). Concomitant medications included hydrochlorothiazide (+) lisinopril and LIPITOR. On 06Jul2010, the patient reported he now has shingles. No diagnostic laboratory studies were performed. The patient sought unspecified medical attention. Follow up information has been received indicating that the patient's adverse event was that he developed herpes zoster despite being vaccinated for it several months earlier. Additional information has been requested.
Numbness from the bottom of neck to the top of head on the left side and the top 1/4 of head on the right side.; Numbness extended to top of tongue; Numbness extended to mouth; Tingling from the bottom of neck to the top of  head on the left side and the top 1/4 of  head on the right side.; Cheek was tight; Cheek was swollen; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included back pain, surgery (spinal fusion L4-S1) in 2014, current herniated disk, bulging disk/degenerative disk disease and bursitis. Patient previously received penicillin, sulfa and biaxin and experienced allergy. Concomitant medications included pregabalin (LYRICA), etodolac (LODINE), tramadol (MANUFACTURER UNKNOWN), tizanidine (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) all for unknown indications from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 13:30, the patient experienced numbness and tingling from the bottom of neck to the top of head on the left side and the top 1/4 of head on the right side. The numbness extended in mouth and the top of tongue, but it did not affect the ability to breathe or speak, cheek was tight and swollen for almost three days. The tingling in face, head lasted for probably one full day but the numbness of tongue went away after about two-three hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of numbness in top of tongue was recovered on 17Mar2021 and the clinical outcome of tingling from the bottom of neck to the top of head on the left side and the top 1/4 of head on the right side was recovered on 18Mar2021. The clinical outcome of the event cheek tightness and cheek swollen was recovered on 20Mar2021. The clinical outcome of the event numbness from the bottom of  neck to the top of head on the left side and the top 1/4 of my head on the right side and numbness extended in mouth was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Starting 05/22/2022 I started getting a scratchy throat and I thought it was allergies. The next day, the scratchy throat got worse. On 05/24/2022, the scratchy throat got worse and I developed post nasal drip and pressure in my ears. I took an at home test and it came back inaccurate. I took an at home test the next day (05/25/2022) and it was very positive. I went to the urgent care and they did a rapid PCR test and it was positive. I was given the option for Monoclonal Antibodies and my son got me into the hospital for treatment the following morning at 6AM. Within 24 hours of receiving treatment, I was fine. I still have a little bit of post nasal drip but that's it. My pulse ox stayed good the entire time.
Patient came in with parent, they did not believe patient had vaccinations and wanted them given that day.  Nothing was showing up in system.  4 shots were administered.  Later found out that the name and date of birth were incorrect.  Once that was updated, we found that the children were completely up to date.  Parent reported the patient had no adverse outcomes from additional vaccines.
Apprx. 05/02/2003, client noted pain in left fingers, hand and wrist progressed to right fingers, hand and wrist and to both elbows. Also had weakness in both legs. Pain was very bad in left and right hands, fingers, wrists 05/04/2003. Has had some swelling of fingers both hands. taking Ibuprphen. has less pain today 05/05/2003 than yesterday.
My nurse gave the Bivalent Booster believing the patient had the primary series already but this ended up to not be the case.  No side effects reported.
Very sore arm at injection site, headache all day, feeling tired, muscle aches. All of these symptoms lasted for about 12 hours and started about 18 hours after I receiving the vaccine.
Skin on inside of arm (opposite side from ZOSTAVAX injection site) became red, swollen, warm, and painful to touch. Attempts to follow up lot pt were unsuccessful. No treatments done that we are aware of.
Diarrhea; Cramps; Sweating; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating) and PYREXIA (Low grade fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating) and PYREXIA (Low grade fever). At the time of the report, DIARRHOEA (Diarrhea), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating) and PYREXIA (Low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
After receiving both the 1st and the 2nd doses of the COVID-19 Pfizer vaccines, long haul symptoms of dysautonomia significantly worsened as well as developing peripheral neuropathy.  This specific event that led to going into the Emergency Room involved  palpitations, tachycardia,  dizziness, numbness in hands, lower left leg pain.  It was dismissed by the ER doctors as anxiety after tests came back normal, but patient was able to finally get referred to a neurologist due to the numb hands which led to a correct diagnosis and medications to reduce the symptoms. Vaccine-induced symptoms have resolved due to treatment.
This spontaneous report as received from a nurse refers to a patient of unknown gender, currently 5 year old. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported. On an unknown date the patient was vaccinated with improperly stored VARIVAX (lot # R018143, expiry date: 25-JUN-2020) (dose and frequency were not reported) subcutaneously for prophylaxis. The VARIVAX was stored in temperature of 15 degree Fahrenheit (F) to 46 F (-9 degree Celsius (C) to 8 C) (25.2F) for 13 hours 36 minutes. There was no previous temperature excursion reported. A digital data logger was involved. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1811USA002375: Original Case : 1811USA002232 US-009507513-1811USA002232: Original Case : 1811USA002232 US-009507513-1811USA002374: Original Case : 1811USA002232 US-009507513-1811USA002371: Original Case : 1811USA002232 US-009507513-1811USA002372: Original Case : 1811USA002232 US-009507513-1811USA005284:
Tested positive for Covid-19 on 1/11 which was 4 days after receiving vaccine.
Within a few weeks after my first COVID vaccine, I started experiencing an increased heart rate (as measured with my STRAVA app), trembling hands, fatigue, and hair loss. By the end of June I also developed severe fatigue, diarrhea, racing heart, and weight loss. Blood tests in July indicated hyperthyroidism. Follow-up bloodwork indicated Grave's disease.
2/28/2022  received  moderna booster  & 3/1 awoke not feeling well. woke w pain in L arm , had  headache , took Tylenol , SOB, CP &  fatigue   3/1 @ 10PM still c/o CP, fatigue 3/3 CP, HA, SOB resolved. Still c/o L axillary & arm pain , fatigue Pt. going to urgent care 3/4  #1 & #2 Moderna Pt c/o arm pain, fatigue & HA
8/13/97, pt's legs and feet gave way. He was bow-legged in lower legs and his feet turned in. Pt noted to have poor eye contact at 18 mos of age at which time milk addiction also started. 02/12/1999 pt had hypotonia throughout extremities and trunk. 7/1/99 pt was intoeing and had poor eye contact. 8/11/99 pt diagnosed as having autism with significant delay in speech.
It is the second shot I had the issue with. I had the same feeling tired and the fishbowl feeling but my arm would not stop itching where I got the shot; It is the second shot I had the issue with. I had the same feeling tired and the fishbowl feeling but my arm would not stop itching where I got the shot; It is the second shot I had the issue with. I had the same feeling tired and the fishbowl feeling but my arm would not stop itching where I got the shot; Covid arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Feb2022 (Lot number: Fm0698) at the age of 31 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Gerd" (unspecified if ongoing); "IBS" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Prev dose product=COVID 19 Pfizer, lot number: Fj6369,, administration date=07Feb2021, dose number=1, location=Left arm), administration date: 07Feb2022, when the patient was 31 years old, for Covid-19 immunization, reaction(s): "The first shot I was tired and I felt like I was in a fishbowl.", "The first shot I was tired and I felt like I was in a fishbowl." The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 01Mar2022, outcome "recovering", described as "Covid arm"; FATIGUE (non-serious), outcome "unknown", FEELING ABNORMAL (non-serious), outcome "recovering" and all described as "It is the second shot I had the issue with. I had the same feeling tired and the fishbowl feeling but my arm would not stop itching where I got the shot"; VACCINATION SITE PRURITUS (non-serious) with onset 01Mar2022, outcome "recovering", described as "It is the second shot I had the issue with. I had the same feeling tired and the fishbowl feeling but my arm would not stop itching where I got the shot". Therapeutic measures were taken as a result of pain in extremity, vaccination site pruritus. Therapeutic measures were not taken as a result of feeling abnormal.  Additional information: Facility type vaccine: Pharmacy or Drug Store. It was the second shot patient had the issue with. He had the same feeling tired and the fishbowl feeling but his arm would not stop itching where he got the shot. After about two weeks, he went back to the pharmacy and asked. The pharmacist said that it sounded like COVID arm. He had tried heating pad, ice, and rubbing it. He also started using some hydrocortisone cream. It was getting better and not as itching him. No COVID prior vaccination. Not tested COVID post vaccination. No other vaccine in four weeks.  Follow-up attempts are completed. No further information is expected.
Client awoke this am with swollen inflamed L deltoid post DTaP approx 10:30 8/8/02. Is recovering.
Bruising in both arms. Bruise in left arm visible when patient reported to the pharmacy. Bruise in right arm was not visible at the time of reporting but the patient stated there was a bruise there.
Needle and syringe became separated while administering the shot to the patient. Unsure of how much if any of the vaccine that the patient received. Re-administered the dose.
lower back muscle pain ; when lying in bed there is no pain; try to move on other side to slip  its suvire pain, try to get up from bed sharp pain to;  I am waking in kind S position  with pain;  some hrs are better than others with ability to walk; samtimes can stright up others dont
Complete inability to sleep .  Edd 1/28/23.  Pregnancy uncomplicated .
Arm was red, itchy, warm; Arm was red, itchy, warm; Arm was red, itchy, warm; swollen lymph node under her injection arm, an axillary node; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm was red, itchy, warm), PRURITUS (Arm was red, itchy, warm), SKIN WARM (Arm was red, itchy, warm) and VACCINATION SITE LYMPHADENOPATHY (swollen lymph node under her injection arm, an axillary node) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (swollen lymph node under her injection arm, an axillary node). On 16-Jan-2021, the patient experienced ERYTHEMA (Arm was red, itchy, warm), PRURITUS (Arm was red, itchy, warm) and SKIN WARM (Arm was red, itchy, warm). On 18-Jan-2021, ERYTHEMA (Arm was red, itchy, warm) had resolved. At the time of the report, PRURITUS (Arm was red, itchy, warm) and SKIN WARM (Arm was red, itchy, warm) had not resolved and VACCINATION SITE LYMPHADENOPATHY (swollen lymph node under her injection arm, an axillary node) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jan-2021: Update on AE, additional AEs reported, not pregnant, no treatment, has not seen HCP.
This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (has Covid) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Overweight. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (has Covid). At the time of the report, COVID-19 (has Covid) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101°f (High) 101°F. It was reported that patient was offered monoclonal infusion because of his age. No concomitant medications were reported. It was reported that patient had very mild symptoms: 101°F temperature, sniffles, barely coughing. Company comment: This spontaneous case concerns a 78-year-old XX patient, with no relevant medical history, who experienced the non-serious unexpected AESI of COVID-19. Onset date of the event and vaccination dates were not reported; however, the narrative states that patient had received the second dose of mRNA-1273 more than 6 months prior to the event. Monoclonal infusion therapy was offered; however, it is it not clear if patient received it. No further clinical information was available for medical reviewing. The benefit-risk relationship of mRNA-1273 is not affected by this report. This case was linked to MOD-2022-438394 (Patient Link). Sender's Comments: This spontaneous case concerns a 78-year-old XX patient, with no relevant medical history, who experienced the non-serious unexpected AESI of COVID-19. Onset date of the event and vaccination dates were not reported; however, the narrative states that patient had received the second dose of mRNA-1273 more than 6 months prior to the event. Monoclonal infusion therapy was offered; however, it is it not clear if patient received it. No further clinical information was available for medical reviewing. The benefit-risk relationship of mRNA-1273 is not affected by this report.
fever, generalized muscle ache, diarrhea, loss of appetite, weakness  - lasted for three days - took 1  1/2 week to fully recover
non elevated rash devel in face only; no other sx DPH, observation for 1 hr post administration of DPH;
Received Pfizer COVID vaccine on 1/4/21 (1st dose) and 1/29/2021 (2nd dose) and developed sores with pus on his lips and difficulty swallowing around 1/20/2021 and dark red toes since receiving 2nd COVID vaccine on 1/29/2021..  Pt presented to ER on 2/1 and prescribed ceftin 500mg bi x10days (2/1-2/5), but based on lip culture that grew out MSSA, pt was switched to doxycycline 100mg po bid on 2/5/2021.    Pt presented outpt clinic on 2/9 since rash got worse.  Ceftin/doxy were dc'd.  Allopurinol and colchicine were dc'd.  Pt received prednisone burst x14days (2/9-2/23) which then got extended for another 21days.  Due to lack of improvement on oral prednisone, dermatology wanted to increase prednisone and start Imuran.  Pt ended up getting admitted to hospital on 3/15/2021.  Pt was started on cyclosporine modified 150mg po bid and prednisone 60mg daily and got discharged on on 3/22/2021.  Pt got re-admitted to hospital on 3/27/2021 for septic arthritis of R knee.
Mom and baby were out shopping and mom noted baby to be limp and then she started jerking and foaming at the mouth. She was unresponsive. Dx'd with Herpes Simplex. Diagnosed with seizure episode